Didanosine adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Didanosine}} {{CMG}}; {{AE}} {{AZ}} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Didanosine}} | {{Didanosine}} | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==ADVERSE REACTIONS== | |||
The following adverse reactions are discussed in greater detail in other sections: | |||
*:[[Pancreatitis]] | |||
*:Lactic acidosis/severe hepatomegaly with steatosis | |||
*:Hepatic toxicity | |||
*:Non-cirrhotic portal hypertension | |||
*:[[Peripheral neuropathy]] | |||
*:Retinal changes and [[optic neuritist]] | |||
==References== | ==References== | ||
Revision as of 20:20, 1 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
ADVERSE REACTIONS
The following adverse reactions are discussed in greater detail in other sections:
- Pancreatitis
- Lactic acidosis/severe hepatomegaly with steatosis
- Hepatic toxicity
- Non-cirrhotic portal hypertension
- Peripheral neuropathy
- Retinal changes and optic neuritist
References
Adapted from the FDA Package Insert.